A pharmaceutical company settled a patent infringement abbreviated new drug application (ANDA) lawsuit that it had filed against a competitor for anticipated marketing of a generic version of one of its products. Alison Baldwin represented the pharmaceutical company in the litigation, which settled favorably after trial but before the court issued its final order.
Pharmaceutical Company Settles Patent Infringement ANDA Lawsuit
Lead Contacts
